Luteolin Arrests Cell Cycling, Induces Apoptosis and Inhibits the JAK/STAT3 Pathway in Human Cholangiocarcinoma Cells
出版年份 2014 全文链接
标题
Luteolin Arrests Cell Cycling, Induces Apoptosis and Inhibits the JAK/STAT3 Pathway in Human Cholangiocarcinoma Cells
作者
关键词
-
出版物
Asian Pacific Journal of Cancer Prevention
Volume 15, Issue 12, Pages 5071-5076
出版商
Asian Pacific Organization for Cancer Prevention
发表日期
2014-09-17
DOI
10.7314/apjcp.2014.15.12.5071
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Luteolin Induced-growth Inhibition and Apoptosis of Human Esophageal Squamous Carcinoma Cell Line Eca109 Cells in vitro
- (2013) Ting-Ting Wang et al. Asian Pacific Journal of Cancer Prevention
- Apoptosis in Cancer - An Update
- (2013) S. Leena Sankari et al. Asian Pacific Journal of Cancer Prevention
- Comparative Studies to Evaluate Relative in vitro Potency of Luteolin in Inducing Cell Cycle Arrest and Apoptosis in HaCaT and A375 Cells
- (2013) Vazhapilly Cijo George et al. Asian Pacific Journal of Cancer Prevention
- Suppression of Ku80 Correlates with Radiosensitivity and Telomere Shortening in the U2OS Telomerase-negative Osteosarcoma Cell Line
- (2013) Liu Hu et al. Asian Pacific Journal of Cancer Prevention
- Treatment Outcome of Palliative Chemotherapy in Inoperable Cholangiocarcinoma in Thailand
- (2013) Kritiya Butthongkomvong et al. Asian Pacific Journal of Cancer Prevention
- Cdks, cyclins and CKIs: roles beyond cell cycle regulation
- (2013) S. Lim et al. DEVELOPMENT
- Luteolin Induces Growth Arrest in Colon Cancer Cells Through Involvement of Wnt/β-Catenin/GSK-3β Signaling
- (2013) Ashok Kumar Pandurangan et al. JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY
- Luteolin Inhibits Human Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2-Mediated Angiogenesis
- (2013) Poyil Pratheeshkumar et al. PLoS One
- Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment
- (2013) Hasaya Dokduang et al. TUMOR BIOLOGY
- Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition
- (2012) Jun-shan Ruan et al. ACTA PHARMACOLOGICA SINICA
- Expression and Clinical Significance of STAT3, P-STAT3, and VEGF-C in Small Cell Lung Cancer
- (2012) Xue Zhao et al. Asian Pacific Journal of Cancer Prevention
- Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells
- (2012) Eun-Ju Lee et al. FOOD AND CHEMICAL TOXICOLOGY
- The tumorigenic liver fluke Opisthorchis viverrini – multiple pathways to cancer
- (2012) Banchob Sripa et al. TRENDS IN PARASITOLOGY
- Cell invasion through basement membrane: the anchor cell breaches the barrier
- (2011) Elliott J Hagedorn et al. CURRENT OPINION IN CELL BIOLOGY
- CDC25 Phosphatase Inhibitors: An Update
- (2011) A. Lavecchia et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Redox modulation and human bile duct cancer inhibition by curcumin
- (2010) Bunliang Suphim et al. FOOD AND CHEMICAL TOXICOLOGY
- Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis
- (2010) Suksanti Prakobwong et al. INTERNATIONAL JOURNAL OF CANCER
- Epigenetic Alterations in Cholangiocarcinoma-Sustained IL-6/STAT3 Signaling in Cholangio- carcinoma due to SOCS3 Epigenetic Silencing
- (2009) Hajime Isomoto DIGESTION
- Distribution and Biological Activities of the Flavonoid Luteolin
- (2009) Miguel Lopez-Lazaro MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Inflammatory cytokines suppress NAD(P)H:quinone oxidoreductase-1 and induce oxidative stress in cholangiocarcinoma cells
- (2008) Auemduan Prawan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started